Trends in the Access and Cost of Photodynamic Therapy Among Medicare Beneficiaries in the United States, 2012-2017

JAMA Dermatol. 2020 Sep 1;156(9):1021-1022. doi: 10.1001/jamadermatol.2020.2427.

Abstract

This cross-sectional study evaluates the geographical variation in the availability of photodynamic therapy for the Medicare population in the United States and characterizes the temporal trends of photodynamic therapy cost and use from 2012 to 2017.

Publication types

  • Letter

MeSH terms

  • Cross-Sectional Studies
  • Health Services Accessibility / economics
  • Health Services Accessibility / statistics & numerical data
  • Health Services Accessibility / trends*
  • Humans
  • Insurance, Health, Reimbursement / economics
  • Insurance, Health, Reimbursement / statistics & numerical data
  • Insurance, Health, Reimbursement / trends
  • Keratosis, Actinic / drug therapy*
  • Keratosis, Actinic / economics
  • Medicare / economics*
  • Medicare / statistics & numerical data
  • Photochemotherapy / economics
  • Photochemotherapy / statistics & numerical data
  • Photochemotherapy / trends*
  • Rural Population / statistics & numerical data
  • Rural Population / trends
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / economics
  • United States
  • Urban Population / statistics & numerical data
  • Urban Population / trends